BDX
Becton, Dickinson and Company · Healthcare · Medical - Instruments & Supplies
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -1.6% · neue Nettopositionen -4.2% · Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 181.83K | $32.35M | n/a | n/a |
| Q2 2026 | 160 | -1 | 195.22M | $30.73B | +7 | −7 |
| Q1 2026 | 163 | -3 | 192.59M | $31.06B | +5 | −9 |
| Q4 2025 | 165 | -1 | 211.71M | $41.08B | +1 | −1 |
| Q3 2025 | 24 | 0 | 114.22M | $21.37B | +1 | −2 |
| Q2 2025 | 22 | 0 | 103.94M | $17.90B | +2 | −2 |
| Q1 2025 | 19 | 0 | 42.24M | $9.67B | +1 | −1 |
| Q4 2024 | 19 | 0 | 42.40M | $9.62B | +1 | −1 |
| Q3 2024 | 18 | -1 | 28.02M | $6.75B | n/a | −1 |
| Q2 2024 | 19 | n/a | 28.10M | $6.56B | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 32.46M | +0.5% | $6.07B | 0.1% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passiv) | 27.75M | +1.7% | $5.19B | 0.1% | ▲ Add | 2 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (passiv) | 13.87M | +3.4% | $2.60B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 10.58M | n/a | $1.98B | 0.1% | n/c | 1 | SEC ↗ ×40 |
| 5 | Geode Capital Management ✦ (passiv) | 6.83M | +1.6% | $1.27B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 5.23M | +9056.3% | $979.29M | 0.2% | ▲ Add | 6 | SEC ↗ ×6 |
| 7 | T. Rowe Price ✦ | 4.62M | -48.0% | $865.20M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 3.47M | n/a | $648.87M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 9 | Harris Associates (Oakmark) ✦ | 3.12M | +6.8% | $583.10M | 0.9% | ▲ Add | 4 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 1.84M | n/a | $345.10M | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 11 | Starboard Value ✦ | 1.21M | -53.9% | $226.10M | 4.3% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.03M | +53.8% | $190.62M | 0.1% | ▲ Add | 6 | SEC ↗ ×6 |
| 13 | Fidelity (FMR) ✦ | 1.00M | -6.9% | $188.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 14 | Arrowstreet Capital ✦ | 370.01K | +87.5% | $69.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 358.56K | -68.5% | $67.11M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | D. E. Shaw & Co. ✦ | 164.03K | -86.9% | $30.70M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 150.59K | +59.4% | $28.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | Millennium Management ✦ | 73.58K | +15.9% | $13.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 34.99K | -96.4% | $6.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 32.70K | -79.8% | $6.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 9.57K | +0.6% | $1.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 9.50K | +1.3% | $1.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Marshall Wace ✦ | 3.30K | -89.6% | $618,223 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 1.21K | Neu | $227,384 | 0.0% | New | 1 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Fisher Asset Management | $227,384 | 0.0% |
Ausgestiegen
| Norges Bank | $653.38M | war 0.1% |
| Renaissance Technologies | $46.75M | war 0.1% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1,452 Inhaber, 258.69M Anteile, $38.42B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer · 76 Ant. · $13,961
Officer · 165 Ant. · $31,101
Officer, Director · 4.15K Ant. · $768,120
Officer · 2.44K Ant. · $440,888
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik